A Sanofi case study in lung cancer

How to dramatically accelerate clinical trials and sustain lower costs in complex and competitive environments

Why This Webinar

The rising costs of drug development have teams at every level of the process seeking new ways to streamline operations and cut expenses, especially in complex and competitive environments such as lung cancer. In this webinar we will share how Sanofi effectively planned for an upcoming lung cancer study while focusing on internal cost reduction goals.

In this webinar we showcase how Sanofi was able to identify a far greater pool of sites with a high recruitment potential by utilizing latest machine learning technologies and combining internal and external databases. An innovative approach to study planning resulted in cost savings through the reduced number of countries and sites, and greater efficiency across the trial.

Webinar agenda Includes:

  • How to accelerate data collection across 47 countries
  • How to increase access to new sites and gain faster access to more patients
  • How to develop an evidence-based recruitment scenario
  • Next steps to improve country and site selection



Caroline Lafitte
Global Head, Feasibility and Competitive Intelligence

Caroline Lafitte is leading a global team in charge of Competitive Intelligence and Feasibility within the Clinical Sciences Operational platform of Sanofi R&D. Caroline is in charge of Feasibility since more than 15 years and experienced in all therapeutic areas covered by Sanofi from Oncology to Rare Disorders, Blood disorders, Neurology and previously Diabetes and Cardiovascular. Her team is in charge of supporting protocol optimization of our study design as well as to define the most appropriate geographical distributions of our clinical studies using new technology, digital andreal worlddata. Caroline spent all of her career in R&D at various positions in Development within pharma industries. She started to work for Sanofi in 2002 and has a PHD in Physiology by training.


Liz Beatty
Chief Strategy Officer

Liz Beatty is the Chief Strategy Officer at Inato, whose platform increases the pool of available patients engaged in clinical trials by unlocking research site potential. Liz is focused on advancing Inato’s corporate strategy, developing partnerships and driving growth in North America. Previously, Liz was the Head of the Digital Clinical Trials team in Global Clinical Operations at Bristol-Myers Squibb. Her team leveraged innovative approaches to increase clinical trial awareness, transparency and participation, resulting in an enhanced clinical trial experience for patients and their care team. She was also the Chair of the Digital Acorn working group, which was a global, cross-functional team that brought digital innovation to clinical trials.  Liz previously held positions in clinical operations including managing a global patient recruitment team as well as various positions in protocol management and site management.  

Keep in touch with Inato by our newsletterSubscribe